The University of Edinburgh
Role of the gut microbiota in Clostridioides difficile Infection
Abstract
dc:description.abstractClostridioides difficile infection (CDI) is caused by the anaerobic, spore-forming bacterium C. difficile. In the US there are approximately 500,000 cases of CDI a year and 15,000 deaths. In Scotland, from 2011-2020 there were 60-209 deaths per annum in which CDI was listed as a contributory factor in the death. CDI is traditionally considered as a hospital-acquired infection although approximately 40% of cases are community-acquired. CDI patients are also at risk from relapsing infection which affects 20-30% of patients, with the risk of future relapse and mortality growing with each subsequent relapse. The gut microbiota provides a protective barrier against CDI via colonisation resistance; essentially, the host’s gut microbiota prevents colonisation by C. difficile. One proposed mechanism of resistance is that members of the host gut microbiota convert primary bile acids which C. difficile spores use to germinate into secondary bile acids. This resistance is lost after exposure to antibiotics which kill the bacteria within the host gut microbiome that convert primary into secondary bile acids. Faecal samples were gathered from approximately 400 patients and community volunteers from the NHS Lothian region in Scotland. Total DNA was extracted from these samples and the V4 region of the 16S rRNA gene amplified via the PCR. The amplified samples were pooled and sequenced alongside mock communities by sequencing the pooled amplicons on the Illumina MiSeq platform. The mock community samples were used to determine if the bioinformatics platform QIIME (quantitative insights into microbial ecology) and operational taxonomic units (OTUs) or QIIME2 and amplicon sequence variants (ASVs) were the most appropriate approach to analysing the data. The patient and volunteer data were analysed using QIIME2 and ASVs; comparisons of alpha-diversity, beta-diversity and differential abundances were made between patient and volunteer groups and within patient groups to explore any differences in the gut microbiota. Results show a higher level of inter-individual variation within the patient groups than the volunteer group. In volunteers, alcohol consumption had an impact on the diversity of the gut microbiota but this difference was not seen in CDI patient groups. In CDI patients, patient location and antibiotic history affected the gut microbiota. Results highlight the difficulty of using such methods diagnostically/clinically in the presence of a high background of inter-individual variation.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2023
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Irvine, Amy
- Advisors dc:contributor.advisor
-
- Free, Andrew
- Moncayo-Nieto, Olga
Subjects
dc:subject × 6Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- http://dx.doi.org/10.7488/era/3955